Insight Molecular Diagnostics Inc. (IMDX) Free cash flow 2016–2025
Insight Molecular Diagnostics Inc. (IMDX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$25.4MFY2025 · since FY2016: -$7.6M → -$25.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.4M | -19.6% |
| FY2024 | -$21.2M | +10.2% |
| FY2023 | -$23.6M | +52.7% |
| FY2022 | -$49.9M | -30.7% |
| FY2021 | -$38.2M | -40.4% |
| FY2020 | -$27.2M | -31.9% |
| FY2019 | -$20.6M | -76.7% |
| FY2018 | -$11.7M | +13.3% |
| FY2017 | -$13.5M | -76.7% |
| FY2016 | -$7.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice